Parker Institute’s Quest to Make Immunotherapy Work in Solid Tumors

“The most effective therapies for solid tumors are also the most toxic — and we need to fix that,” says Dr. John Connolly, chief scientific officer of the Parker Institute for Cancer Immunotherapy.